Nel ASA’s Split Personality: Charts Flash Buy, Analysts Shout Sell

Nel ASA shares drop 9% as analysts unanimously rate sell, yet technicals flash 'Strong Buy'. Revenue misses by 22%, orders plunge 73%, but cash buffer offers relief.

Nel ASA shares find themselves trapped between two conflicting narratives. The stock tumbled as much as 9% to €0.32 on Monday before paring losses to trade around €0.34, still down 2.4%. The retreat comes just a week after the hydrogen specialist hit a 52-week high of €0.36, meaning the equity has now surrendered roughly 11% of that peak. The pullback lays bare a widening chasm: the market has been pricing in a recovery that analysts insist is not yet justified by the numbers.

Seven research houses currently carry sell ratings on the Oslo-listed stock, with not a single buy recommendation in sight. The average 12-month price target stands at 2.12 Norwegian kroner, and even the most optimistic forecast of 4.2 kroner falls short of recent trading levels. Berenberg recently trimmed its target to 2.30 kroner while sticking with a “Neutral” rating, citing valuation risks. Citigroup followed suit, cutting its target to 2.40 kroner. Both levels sit deep below the current market price, underscoring a rare disconnect between Wall Street and the trading floor.

The fundamental picture reinforces the bearish stance. Nel missed first-quarter expectations by a wide margin, posting a loss per share of ?0.08 kroner against consensus estimates of ?0.06 kroner – a miss of nearly 38%. Revenue from customer contracts came in at 148 million kroner, with total revenue including other income reaching 152 million, well short of the 194 million kroner analysts had penciled in. That 22% revenue miss follows a grim 2025, when turnover contracted 30.7% and losses ballooned by 417.8% year-on-year.

Order intake, the lifeblood of any project-based business, tells the most troubling story. Nel booked just 85 million kroner in new orders during the first quarter, a staggering 73% drop from the prior-year period. The order backlog shrank to 1.113 billion kroner, down 24% from a year ago and 16% from the previous quarter. The slump in visible business raises questions about whether the recent rally was built on hydrogen euphoria rather than concrete project momentum.

Technical indicators, however, paint a markedly different picture. Investing.com upgraded the stock to “Strong Buy” in its daily assessment on June 1, with the two-week relative strength index settling at a neutral 52.336 and the MACD flashing a buy signal at 0.080. Yet the detail table reveals a more nuanced picture: four buy signals, three neutral signals and three sell signals, while moving averages stood deadlocked at six buys and six sells. The short-term average line at 3.82 generated a sell signal, while the line at 3.55 triggered a buy, suggesting that the medium-term trend still supports the stock but the very near-term momentum has frayed.

The company’s financial buffer offers some solace. Nel held cash and equivalents of 1.443 billion kroner at the end of the first quarter, enough to fund operations through the end of 2026 according to management. Up to 135 million euros in EU Innovation Fund grants could also bolster the new pressure alkaline platform. Still, the idled Herøya facility remains a lingering risk – two production lines there are being evaluated for restart, sale or permanent closure, and a potential impairment charge could hit the half-year results.

Nel’s position in the hydrogen ecosystem keeps it on institutional radar. The US-listed Global X Hydrogen ETF counted Nel as a top holding as of May 29, with a 5.12% weighting. The fund owned roughly 20.6 million shares worth $8.59 million out of total assets of $167.96 million. That allocation does not validate the current share price, but it confirms that Nel remains a core liquid name for investors targeting electrolysers and hydrogen infrastructure.

The next real test comes on July 15, when Nel releases its half-year report. That earnings day will reveal whether the technical rebound can translate into operational traction – or whether the seven sell ratings and the 73% order collapse are the more reliable guide to where the stock is headed. Until then, the equity sits in a tug-of-war between momentum and reality.